- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
3-V Biosciences
3-V Biosciences is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country and 1 service area.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Where it operates
Sites by country, with the cities in each.
-
United States 1 site
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
3-V is advancing a novel program targeting the fatty acid synthase (FASN) enzyme for the treatment of cancer. FASN over-expression is associated with aggressive disease in multiple tumor types (including breast, prostate and pancreatic cancers) and provides an opportunity for patient selection. Our proprietary FASN inhibitors were designed and developed to specifically target FASN and minimize off-target effects. In preclinical studies, our FASN inhibitors have demonstrated potent activity against a number of tumor types, potential synergy with approved cytotoxic agents, and excellent...
Show the full description
3-V is advancing a novel program targeting the fatty acid synthase (FASN) enzyme for the treatment of cancer. FASN over-expression is associated with aggressive disease in multiple tumor types (including breast, prostate and pancreatic cancers) and provides an opportunity for patient selection. Our proprietary FASN inhibitors were designed and developed to specifically target FASN and minimize off-target effects. In preclinical studies, our FASN inhibitors have demonstrated potent activity against a number of tumor types, potential synergy with approved cytotoxic agents, and excellent tolerability. 3-V is planning to file an IND and initiate a Phase 1 clinical trial for this program in 2013.
Novel Antviral Targets Charact
- Website
- www.3vbio.com
Work with 3-V Biosciences on Scientist.com
For prices, more details, or to contact 3-V Biosciences, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.